229 related articles for article (PubMed ID: 30001387)
1. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S
PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387
[TBL] [Abstract][Full Text] [Related]
2. Ki67, CD105, and α-SMA expressions better relate the binary oral epithelial dysplasia grading system of World Health Organization.
Gadbail AR; Chaudhary MS; Sarode SC; Gawande M; Korde S; Tekade SA; Gondivkar S; Hande A; Maladhari R
J Oral Pathol Med; 2017 Nov; 46(10):921-927. PubMed ID: 28672080
[TBL] [Abstract][Full Text] [Related]
3. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
4. Ki67, CD105 and α-smooth muscle actin expression in disease progression model of oral submucous fibrosis.
Gadbail AR; Chaudhary MS; Sarode SC; Gondivkar SM; Belekar L; Mankar-Gadbail MP; Dande R; Tekade SA; Yuwanati MB; Patil S
J Investig Clin Dent; 2019 Nov; 10(4):e12443. PubMed ID: 31325233
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study.
Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS
J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271
[TBL] [Abstract][Full Text] [Related]
6. Comparison of myofibroblasts expression in oral squamous cell carcinoma, verrucous carcinoma, high risk epithelial dysplasia, low risk epithelial dysplasia and normal oral mucosa.
Chaudhary M; Gadbail AR; Vidhale G; Mankar Gadbail MP; Gondivkar SM; Gawande M; Patil S
Head Neck Pathol; 2012 Sep; 6(3):305-13. PubMed ID: 22392407
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):253-259. PubMed ID: 35092395
[TBL] [Abstract][Full Text] [Related]
8. Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study.
Pammar C; Nayak RS; Kotrashetti VS; Hosmani J
J Cancer Res Ther; 2018; 14(5):983-988. PubMed ID: 30197335
[TBL] [Abstract][Full Text] [Related]
9. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J
Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036
[TBL] [Abstract][Full Text] [Related]
10. Myofibroblasts could be recruited in a chemokine (C-C motif) ligand 2-dependent manner in pathogenesis of oral submucous fibrosis.
Sarode G; Sarode SC; Deshmukh R; Raktade P; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):443-447. PubMed ID: 28029690
[TBL] [Abstract][Full Text] [Related]
11. Oral submucous fibrosis: An enigmatic morpho-insight.
Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
13. Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression.
Das RK; Pal M; Barui A; Paul RR; Chakraborty C; Ray AK; Sengupta S; Chatterjee J
J Clin Pathol; 2010 Oct; 63(10):894-9. PubMed ID: 20876321
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study.
Liu Z; Hu W; Shan Z; Liu S; Yao Z; Quan H
J Cancer Res Ther; 2024 Apr; 20(2):706-711. PubMed ID: 38687943
[TBL] [Abstract][Full Text] [Related]
15. Relationship between thickness of fibrosis and epithelial dysplasia in oral submucous fibrosis.
Jayasooriya PR; Nadeeka Jayasinghe KA; Mudiyanselage Tilakaratne W
J Investig Clin Dent; 2011 Aug; 2(3):171-5. PubMed ID: 25426787
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
Shraddha KS; Niranjan KC; Hallikeri K
J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
18. Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Indian J Dent Res; 2022; 33(3):272-276. PubMed ID: 36656187
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
20. Identification of a combined biomarker for malignant transformation in oral submucous fibrosis.
Bazarsad S; Zhang X; Kim KY; Illeperuma R; Jayasinghe RD; Tilakaratne WM; Kim J
J Oral Pathol Med; 2017 Jul; 46(6):431-438. PubMed ID: 27497264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
